Assessment of the licensing and patenting practices of UK's leading medical research institutions

Sarai Keestra made this Freedom of Information request to University of Warwick

This request has been closed to new correspondence from the public body. Contact us if you think it ought be re-opened.

The request was successful.

Dear University of Warwick,

The FOI request below is being filed on behalf of UAEM-UK. Please note that the answers to these questions will be used to determine the university’s score in the forthcoming Global Health Ranking of leading UK universities by Universities Allied for Essential Medicines (UAEM) UK.

We encourage you to read this background briefing before compiling your response:
https://docs.google.com/document/d/1GMzH...

Thank you very much for your time & best wishes,
Sarai Keestra - Universities Allied for Essential Medicines UK

START FOI

For the purpose of clarity, please adhere to the following definitions when answering these questions:

Definitions

Low and middle income country: A country that is defined as ‘low’, ‘lower-middle’ and ‘upper-middle’ income by the World Bank for the year 2018. Income status defined by GNI per capita.
Source: World bank, available online [https://tinyurl.com/jr6s6fm]

Patent: A form of intellectual property (IP) rights protection, whereby a government grants to the inventor, the right to stop others from making, using or selling the product without their permission for a limited period.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Licence: Contracts that transfer IP rights from the owner of the rights to a third party for use.
Source: Upcouncil, available online [https://www.upcounsel.com/copyright-trad...

Exclusive Licence: A licence that allows only the named licensee to exploit the relevant IP rights, the licensor is also excluded from exploiting these IP rights.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Non-Exclusive Licence: A licence that grants any number of licensees to exploit the IP.
Source: TaylorWessing, available online [https://united-kingdom.taylorwessing.com...

Health Technology: ‘Health technology as defined by the WHO: “A health technology is the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives.’ Source: WHO, available online [http://www.who.int/health-technology-ass...

Q1. Has the university committed to licensing its medical discoveries in ways that promote access and affordability in Low- and Middle- Income Countries? If yes, please provide a link or PDF to the relevant policy document.

Q2. Please provide an Excel spreadsheet with headings as displayed below with all the health technologies LICENSED by the university in the past year AND specify which countries they were licensed in AND specify whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License (Exclusive or Non-Exclusive)

Q3. Please provide an Excel spreadsheet with all the health technologies PATENTED by the university in the past year AND specify which countries they were patented in.

Q4.Has the university shared its best practices for promoting access to medicines through non-exclusive licensing by carrying out any of the following activities?
- Contributed sample clauses to the AUTM Global Health Toolkit
- Published an article, guidance, or other literature on access licensing practices
- Formally presented on access licensing practices at an academic or professional event, or at another university
- Informally shared or discussed access licensing practices with administrators at other universities
- Other
- None
(Tick as appropriate)

Q5. What actions has the technology transfer office (TTO) undertaken in the past year to improve access to the technologies they license in low- and middle-income settings?

END FOI

Yours faithfully,

Sarai Keestra

infocompliance, Resource, University of Warwick

Thank you for your email which has been received by the University's
Information and Data Compliance Team. 

The University undertakes to respond to Freedom of Information requests
within 20 working days and to Data Subject Rights Requests within one
month.

If your query is not related to a Freedom of Information request or Data
Subject Rights Request, please could you re-direct your query to
[1][email address].

Information and Data Compliance Team.

References

Visible links
1. mailto:[email address]

Dear University of Warwick,

It has been pointed out to me that the link to the background briefing in our FOI request was broken. Please accept my sincerest apologies for this inconvenience. This link should now be working: https://docs.google.com/document/d/1GMzH...

Yours sincerely,

Sarai Keestra

Dear University of Warwick,

Please pass this on to the person who conducts Freedom of Information reviews.

I am writing to request an internal review of University of Southampton's handling of my FOI request 'Assessment of the licensing and patenting practices of UK's leading medical research institutions'.
The time frame set by law for responding to this FOI request has expired and is currently 14 days (10 working days) overdue. I have not received any clarification as to why my FOI request has been delayed.

Please note that UAEM is planning to compile their global health ranking during the second half of December. The majority of the universities we sent FOI requests to have responded within the legal timeframe. We are therefore highly unlikely to be able to take into account information supplied after the 7th of December. We may be forced to score the university with 0 points on all dimensions if you cannot provide the information requested in our FOI by the 7th of December.

Therefore, I urge you to prioritise responding to this FOI request.

A full history of my FOI request and all correspondence is available on the Internet at this address:
https://www.whatdotheyknow.com/request/a...

Yours faithfully,

Sarai Keestra

infocompliance, Resource, University of Warwick

Dear Sarai Keestra,

Thank you for your emails dated 9^th and 17^th October 2018 requesting
information about the University of Warwick. Your request is being
considered under the Freedom of Information Act 2000. Please find below
your request and our response.

1.            Has the university committed to licensing its medical
discoveries in ways that promote access and affordability in Low- and
Middle- Income Countries? If yes, please provide a link or PDF to the
relevant policy document.

The University of Warwick has made no commitment to access licensing, but
Warwick Ventures, its TTO, is committed to the general principle of access
licensing where appropriate.

2.            Please provide an Excel spreadsheet with headings as
displayed below with all the health technologies LICENSED by the
university in the past year AND specify which countries they were licensed
in AND specify whether they are exclusive or non-exclusive licenses.

Health Technology Licensed | Country of Licensing | Type of License
(Exclusive or Non-Exclusive)

Please find the information requested in the table below:

+----------------------------------------+
| Health technologies licensed by the |
| University of Warwick in year 2017/18 |
| broken down by country and type |
|----------------------------------------|
|Health | Country | Type of |
|technology | of | licence |
| |licensing| |
|----------------+---------+-------------|
|Influenza |The World| Exclusive |
|treatment | | |
|----------------+---------+-------------|
|Antibiotic |The World| Exclusive |
|Target Assay | | |
|----------------+---------+-------------|
|Blood | Europe, | |
|Cyropreservation| US |Non-exclusive|
|Technique | | |
|----------------+---------+-------------|
|Embyro Viability| Europe, |Non-exclusive|
|assay |US, China| |
|----------------+---------+-------------|
|Palpation |The World| Exclusive |
|Training Device | | |
+----------------------------------------+

 

3.            Please provide an Excel spreadsheet with all the health
technologies PATENTED by the university in the past year AND specify which
countries they were patented in.

Please find the information requested in the table below:

+------------------------------+
| Health technologies patented |
| by the University of Warwick |
| in 2017/18 broken down by |
| country |
|------------------------------|
|Health technology | Country |
|------------------+-----------|
|Urinary Health | GB |
|Screen |Provisional|
|------------------+-----------|
|3D printed, | |
|controlled-release| GB |
|drug delivery |Provisional|
|devices | |
|------------------+-----------|
|Novel Enacyloxin | GB |
|Derivatives |Provisional|
|------------------+-----------|
|Clinical tests for| |
|Autism based on | GB |
|plasma and urinary|Provisional|
|biomarkers | |
|------------------+-----------|
|Novel Polymer | |
|Cryoprotectants | GB |
|for Cell |Provisional|
|Preservation | |
|------------------+-----------|
|Fast bacterial | GB |
|detection and |Provisional|
|discrimination | |
|------------------+-----------|
|Gland and Lumen | GB |
|identification and|Provisional|
|segmentation | |
|------------------+-----------|
|Precise Tumor | |
|Segmentation of | GB |
|Histology Images |Provisional|
|using Recurrent | |
|Models | |
|------------------+-----------|
|Embryo Viability | Europe, |
|Assay | China, US |
+------------------------------+

 

Data notes:

·         Please note that the number of patent applications of health
technologies a university can make is dependent on the capacity of the
research base and the patent budget available to the TTO.  The University
of Warwick does not have the budget to file patent applications
extensively at the national phase (i.e. in each country).

4.            Has the university shared its best practices for promoting
access to medicines through non-exclusive licensing by carrying out any of
the following activities?

•             Contributed sample clauses to the AUTM Global Health Toolkit

No

•             Published an article, guidance, or other literature on
access licensing practices

No

•             Formally presented on access licensing practices at an
academic or professional event, or at another university

No

•             Informally shared or discussed access licensing practices
with administrators at other universities –

Yes

•             Other

•             None

(Tick as appropriate)

5.         What actions has the technology transfer office (TTO)
undertaken in the past year to improve access to the technologies they
license in low- and middle-income settings?

0-20% of health technology licences included provisions promoting access
in LMICs.

If you are unhappy with the way in which your request has been handled by
the University of Warwick, you can request an internal review within one
calendar month from the date of receipt of the original response to the
Freedom of Information request, and in the first instance you are advised
to follow the procedure outlined here:
[1]http://www2.warwick.ac.uk/services/legal...

Yours sincerely,

Helen Pennack

Helen Pennack | Director of University Marketing and Communication |
External Affairs
University House | University of Warwick | Coventry | CV4 8UW

 

References

Visible links
1. http://www2.warwick.ac.uk/services/legal...